Natera, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Natera, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $53.77M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $56.66M | Mar 15, 2018 |
| FY2017 | Jun 30, 2017 | $53.62M | Mar 15, 2018 |
| FY2017 | Mar 31, 2017 | $46.90M | Mar 15, 2018 |
| FY2017 | Dec 31, 2016 | $49.30M | Mar 15, 2018 |
| FY2017 | Sep 30, 2016 | $53.89M | Mar 15, 2018 |
| FY2017 | Jun 30, 2016 | $51.98M | Mar 15, 2018 |
| FY2017 | Mar 31, 2016 | $61.90M | Mar 15, 2018 |
| FY2016 | Dec 31, 2015 | $52.91M | Mar 16, 2017 |
| FY2016 | Sep 30, 2015 | $44.92M | Mar 16, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.70B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $820.22M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $625.49M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $391.01M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $83.24M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $77.91M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $74.36M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $66.82M | Mar 2, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $52.91M | Mar 24, 2016 |
| FY2015 | Sep 30, 2015 | $44.92M | Mar 24, 2016 |
| FY2015 | Jun 30, 2015 | $45.09M | Mar 24, 2016 |
| FY2015 | Mar 31, 2015 | $47.44M | Mar 24, 2016 |
| FY2015 | Dec 31, 2014 | $49.88M | Mar 24, 2016 |
| FY2015 | Sep 30, 2014 | $46.27M | Mar 24, 2016 |
| FY2015 | Jun 30, 2014 | $35.84M | Mar 24, 2016 |
| FY2015 | Mar 31, 2014 | $27.30M | Mar 24, 2016 |
| FY2015 | Dec 31, 2013 | $55.17M | Mar 24, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $38.78M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $34.03M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $30.53M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $23.52M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $24.18M | Mar 2, 2020 |
| FY2019 | Sep 30, 2018 | $23.60M | Mar 2, 2020 |
| FY2019 | Jun 30, 2018 | $22.07M | Mar 2, 2020 |
| FY2019 | Mar 31, 2018 | $21.75M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $15.33M | Mar 15, 2019 |
| FY2018 | Sep 30, 2017 | $21.30M | Mar 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($208.16M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($190.43M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($434.80M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($547.80M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($471.72M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($229.74M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | ($35.18M) | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | ($23.14M) | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | ($32.42M) | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | ($34.09M) | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($309.91M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($222.29M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($446.25M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($541.04M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($468.17M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($216.28M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($116.29M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($114.63M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($135.34M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | ($101.05M) | Mar 15, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $624.11M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $404.14M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $320.68M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $316.42M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $264.21M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $100.04M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $51.36M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $51.36M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $50.06M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $41.86M | Mar 15, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $841.31M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $618.31M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $588.59M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $511.03M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $303.63M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $206.18M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $154.87M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $155.31M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $136.13M | Mar 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $135.66M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($246.96M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($431.50M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($335.24M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($182.51M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($63.44M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($70.58M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($97.83M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | ($74.05M) | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $66.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $39.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $47.70M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $41.03M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $19.60M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $4.97M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $3.88M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $9.87M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $23.14M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.40B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.66B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.44B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.39B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.24B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $932.15M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $582.66M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $268.17M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $214.61M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $210.68M | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $685.93M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $465.32M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $676.37M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $688.73M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $583.18M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $445.92M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $303.95M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $236.01M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $189.20M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $104.20M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.20B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $765.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $705.74M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $653.30M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $486.24M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $278.71M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $32.16M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $25.42M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $143.58M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.07M | Feb 27, 2026 |
| FY2025 | Dec 4, 2025 | $141.10M | Feb 27, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.78B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($2.57B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($2.38B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($1.94B) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($1.39B) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($929.32M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($699.17M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($574.53M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | ($446.38M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($345.85M) | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $466.01M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $84.39M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $48.67M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $61.93M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $46.41M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $12.62M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $15.26M | Mar 15, 2019 |
| FY2018 | Dec 31, 2015 | $28.95M | Mar 15, 2019 |
| FY2017 | Dec 31, 2014 | $87.18M | Mar 15, 2018 |
| FY2016 | Dec 31, 2013 | $30.50M | Mar 16, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $282.95M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $281.65M | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $280.39M | Feb 25, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (5) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | (5) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (5) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | (5) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 139.69M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 132.65M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 119.58M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 111.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 95.14M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 86.22M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 78.01M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 62.08M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 54.04M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 52.67M | Mar 15, 2018 |